The FDA and most pharmaceutical manufacturers recommend avoiding these medications during nursing until more evidence emerges
Impact of patient characteristics on efficacy and safety of once-weekly semaglutide versus dulaglutide: SUSTAIN 7 post hoc analyses
Even after approval, availability may depend on labeling, supply, prescriber adoption, and payer decisions
In clinical trials, tirzepatide has shown superior results in body weight reduction compared to other single-agent medications
These supplements cost less than the prescription GLP-1 drugs, and their development and operating costs are also less since telemedicine isnt required and there is no FDA regulation of supplements
Reduced Food Obsession For many, constant thoughts about eating can be overwhelming